There is mounting interest for researchers to start conducting studies with humans as soon as possible to find a vaccine and therapeutic treatments that are safe and effective, write Hastings Center research scholars Karen Maschke and Michael Gusmano, who also is an associate professor at Rutgers School of Public Health. The authors are “not eager to see Covid-19 interventions join the list of others that entered the clinic on the basis of limited or contested evidence of effectiveness and then harmed patients or proved to be ineffective. ” They suggest that effective strategies to minimize this risk require commitment from scientists, physicians, policymakers, patients, and the general public. To read the full article.
Recent Posts
- Rutgers Physician Assistant Studies is Third in U.S. News and World Report’s Graduate School Rankings.
- Autism Rates Hit Record High, With One in 31 Children Affected, CDC Reports.
- How Much Do You Need to Walk to Offset the Harmful Effects of Sitting? Experts Explain.
- Frequent Use of Antibiotics in Infants and Young Children May Increase Risk for Asthma, Allergies and Other Conditions
- Revealing the Heavy Impacts of Repeated Low-Level Head Traumas.
Categories
- Community (2,260)
- Covid (986)
- CTO Events (6)
- News (2,879)
- Pilots (21)